New York, New York, United States The venture was found in North America in United States. The main office of represented VC is situated in the New York.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Affymax, Raven Biotechnologies, AGY Therapeutics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Pharmaceutical, Medical.
This Bear Stearns Health Innoventures L.P works on 15 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2004. The typical startup value when the investment from Bear Stearns Health Innoventures L.P is 50-100 millions dollars. Speaking about the real fund results, this VC is 69 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2006.
The overall number of key employees were 1.
The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Bear Stearns Health Innoventures L.P, startups are often financed by Alta Partners, Sprout Group, Rho Ventures. The meaningful sponsors for the fund in investment in the same round are Sprout Group, Alta Partners, Yasuda Enterprise Development. In the next rounds fund is usually obtained by Alta Partners, Sprout Group, Yasuda Enterprise Development.
Related Funds
| Fund Name | Location |
| Atoc Holdings | Lynnwood, United States, Washington |
| Beijing Phoenix Wealth Holding Group | - |
| Demarest Media | California, Los Angeles, United States |
| Eaglewings Ventures | India, Maharashtra, Mumbai |
| Flerie Invest | - |
| Freedom Investment Group | Edison, New Jersey, United States |
| Highland Creek Partners | Canada, Ontario, Toronto |
| Humanity United | California, San Francisco, United States |
| InnoSpace | China, Hong Kong, Hong Kong Island |
| KoppiCatch | Finland, Helsinki, Southern Finland |
| M. R. Al Khathlan | - |
| Ohio Biotech Group | - |
| pH Pharma | Seoul, Seoul-t'ukpyolsi, South Korea |
| SE Energi & Klima | Denmark, Esbjerg, Region of Southern Denmark |
| Slant Design + Marketing Inc. | British Columbia, Canada, Vancouver |
| Talwalkars | India, Maharashtra, Mumbai |
| Total Gas & Power | - |
| University of Maryland Global Campus | - |
| Web3 Foundation | Switzerland, Zug, Zug |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
PharmAthene | $50M | 12 Oct 2004 | Annapolis, Maryland, United States | ||
AGY Therapeutics | $9M | 07 Aug 2004 | San Francisco, California, United States | ||
Affymax | $20M | 14 Apr 2004 | Cupertino, California, United States | ||
Raven Biotechnologies | $40M | 03 Jan 2003 | South San Francisco, California, United States | ||
Anesiva | $50M | 23 Jul 2002 | South San Francisco, California, United States | ||
Entelos | $25M | 06 Sep 2001 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
PharmAthene | $50M | 12 Oct 2004 | Annapolis, Maryland, United States | ||
AGY Therapeutics | $9M | 07 Aug 2004 | San Francisco, California, United States | ||
Affymax | $20M | 14 Apr 2004 | Cupertino, California, United States | ||
Raven Biotechnologies | $40M | 03 Jan 2003 | South San Francisco, California, United States | ||
Anesiva | $50M | 23 Jul 2002 | South San Francisco, California, United States | ||
Entelos | $25M | 06 Sep 2001 | California, United States |
